The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmoset

This publication has 18 references indexed in Scilit:

• Selective D-1 dopamine receptor agonist treatment of parkinson's disease
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
• Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393
  Neuropharmacology, 1986
• Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions
  Life Sciences, 1985
• Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats
  European Journal of Pharmacology, 1985
• The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset
  Neuroscience Letters, 1985
• Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats
  Psychopharmacology, 1985
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset
  Neuroscience Letters, 1984
• Unilateral striatal dopamine denervation: Reduced motor inhibitory effects of dopamine antagonists revealed in models of asymmetric and circling behaviour
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984
• The pharmacological evaluation of pergolide mesylate as a potential anti-Parkinson agent
  Neuropharmacology, 1980
• THE EFFECT OF BROMOCRIPTINE ON RAT STRIATAL ADENYLATE CYCLASE AND RAT BRAIN MONOAMINE METABOLISM
  Journal of Neurochemistry, 1978